Michael Mina: Rapid COVID Testing | Lex Fridman Podcast #235

Michael Mina makes the case that rapid at-home antigen tests are the most powerful, doable solution to COVID because they answer the only question that matters for transmission: am I infectious right now? He explains why the FDA's evaluation of these tests as medical devices against the PCR gold standard misclassifies and blocks them, and how a single presidential executive action redefining them as public health tools could unlock hundreds of millions of cheap tests. He critiques the Biden 'vaccinate or test' plan, vaccine over-promising on transmission, and the politicization of testing. The conversation closes with Mina reflecting on his time as a Buddhist monk, meditation, detachment, minimalism, and the future of civilization.

• Rapid tests are ~95-100% sensitive at catching super-spreaders even though a misleading 'average' sensitivity vs PCR makes them look only ~40% sensitive.
  00:09:48
• People are typically infectious for only 3-7 days but can stay PCR-positive for 30-70 days, so PCR can wrongly force isolation long after contagiousness ends.
  00:16:01
• Mina argues one line of presidential executive action designating tests as 'public health tools' could legally bypass the FDA bottleneck.
  00:22:18
• Pooled PCR testing of millions of schoolkids gets no FDA oversight, while a single-sample rapid test for the same purpose requires authorization.
  00:24:21
• Vaccines were authorized on stopping disease, not transmission, which most trials never even measured as a metric.
  00:38:48
• Mina says he is 'sort of serious' about wanting Elon Musk and Tesla engineers to mass-produce rapid tests cheaply.
  00:56:50
• He calls 'vaccinate or test' confusing and wrong; it should be 'vaccinate AND test' because vaccinated people still transmit.
  00:59:56
• Mina reveals he was a Buddhist monk who stopped meditating after living in a refugee camp following the 2004 Indian Ocean tsunami.
  01:31:34

• The virus can grow from zero to a billion copies in a day, so rapid tests don't need extreme sensitivity to catch the infectious window.
  00:07:14
• A rapid test can cost roughly 50 cents to manufacture; in Germany's competitive market they sell for around 80 cents.
  00:46:34
• Germany has authorized 60-70 different high-quality rapid test companies, while the US has very few.
  00:46:34
• Tests are classified as medical devices because the CMS rule says any test that alters a single person's behavior is a medical device.
  00:11:50
• The UK created a fast public-health screening pathway and deployed ranked rapid tests in weeks, not years.
  00:36:44
• Mina frames quarantine and shutdowns as fundamentally information problems, not biological ones.
  01:11:46
• The Biden plan's 280 million tests amounts to less than one test per person per year in the US.
  00:58:54
• Mina predicts that by late 2022 or early 2023 COVID will likely be seen as not particularly dangerous for most people as immunity builds.
  01:16:24
• Mina is pessimistic about the 'American experiment,' suggesting the US may become another power that rose and collapsed.
  01:39:54

Books, products and media the guest or host genuinely endorsed here — with the buy link.

Affiliate link — we may earn a commission at no extra cost to you.